CHA Vaccine Research Institute
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
261780 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 중원구 둔촌대로 560, 406,407호(상대원동, 벽산테크노피아), 성남시
- Website:
- http://en.chavaccine.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
CHA Vaccine Research Institute is a clinical-stage biotechnology company specializing in the development of therapeutic and prophylactic vaccines and immunotherapeutics. A member of the CHA Medical and Bio Group, the company focuses on preventing and treating infectious diseases and cancer. Its core pipeline includes a third-generation hepatitis B (HBV) vaccine, a therapeutic vaccine for chronic HBV, a recombinant zoster (shingles) vaccine, and an improved influenza vaccine. The company leverages proprietary immune adjuvant platform technologies, such as L-pampo, and its own messenger RNA (mRNA) delivery system to enhance vaccine efficacy.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CHA Vaccine Research Institute and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all CHA Vaccine Research Institute filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for CHA Vaccine Research Institute via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
